Patents for A61P 35 - Antineoplastic agents (221,099)
12/1989
12/13/1989EP0345572A2 Sulfonamide derivatives, their preparation and pharmaceuticals containing them
12/13/1989EP0345315A1 Ps2 protein derivative
12/13/1989EP0345308A1 Ornithine derivatives and their use as inhibitors of methotrexate resistant cells.
12/13/1989EP0345294A1 Drugs containing platinum complexes.
12/13/1989EP0345260A1 Method of treatment of mammals using antibodies to early pregnancy factor (epf)
12/13/1989EP0179127B1 Leukoregulin, an antitumor lymphokine, and its therapeutic uses
12/13/1989CN1037904A 3'deamino-4'-deoxy-4'-amino anthracyclines
12/13/1989CN1037898A Aromatic and heterocyclic carboxamide derivatives as antineoplastic agents
12/12/1989US4886907 Polysubstituted derivatives of naphthalene, their process of preparation and their application in the cosmetic and pharmaceutical fields
12/12/1989US4886818 Inhibiting growth of tumors with certain substituted phenoxy dimethyl acids, esters or salts
12/06/1989EP0345171A1 Metalloporphyrine derivatives, their therapeutical use and their use in the preparation of hybrid molecules
12/06/1989EP0345153A1 Affinity markers for hormonal steroid receptors, their use in hormonoradio therapy and as imaging agents of hormone-dependent cancers
12/06/1989EP0344990A1 Mitomycin derivatives and intermediates therefor
12/06/1989EP0344955A2 Novel long-chain glycolipid structure
12/06/1989EP0344922A2 N-(N-(tetrahydropyrido(2,3-d)pyrimidinylmethyl)-aminomethylbenzoyl)glutamic acid derivatives
12/06/1989EP0344880A2 Pharmaceutical compositions with anti-cancer activity
12/06/1989EP0344682A2 Oligopeptides with cyclic analogues of amino acids of proline
12/06/1989EP0344586A2 Medicine containing a TNF inhibitor
12/06/1989EP0344297A1 Treatment of cancer with somatostatin and analogs thereof
12/06/1989EP0209511B1 Hydrochlorides of 2-aminoalkyl-9-hydroxyellipticinium chloride derivatives, and pharmaceutical compositions containing them
12/05/1989US4885308 Method and compositions for treatment of parkinsonism syndrome in mammals
12/05/1989US4885166 Hybrid interferons
12/05/1989CA1263649A1 DERIVATIVE OF .alpha.-.alpha.TREHALOSE AND A PROCESS FOR PREPARING THE SAME
11/1989
11/30/1989WO1989011492A1 Human mammary cell growth inhibitor and methods of production and use
11/30/1989WO1989011491A1 Antibodies to human mammary cell growth inhibitor and methods of production and use
11/30/1989WO1989011487A1 Derivatives of cyclic amp as treatment for cancer
11/30/1989WO1989011484A1 Phosphoramides useful as antitumor agents
11/30/1989WO1989011480A1 SUBSTITUTED 6H-PYRIDO (4,3-b) CARBAZOLES
11/30/1989WO1989011475A1 Macrocyclic chelates and methods of use thereof
11/30/1989WO1989011296A1 Anti-idiotype antibodies to anti-human high molecular weight-melanoma associated antigen
11/30/1989WO1989011292A1 Liposome-encapsulated vinca alkoaloids and their use in combatting tumors
11/30/1989WO1989011290A1 Amphiphilic peptides and use thereof
11/30/1989EP0323462A4 Use of interleukin-1 to induce development of multipotent hemopoietic cell populations.
11/29/1989EP0343893A1 Aromatic and heterocyclic carboxamide derivatives as antineoplastic agents
11/29/1989EP0343801A2 N-(5,6,7,8-tetrahydropyrido(2,3-D)pyrimidin-6-yl-alkanoyl)-glutamic acid derivatives
11/29/1989EP0343772A2 Process for preparing platinum green complex
11/29/1989EP0343480A1 Use of interleukin-2 in the immunostimulation of weakened immune reaction
11/29/1989EP0343388A2 Expression of interferon-gamma in methylotrophic yeasts
11/29/1989EP0343217A1 Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood
11/28/1989US4883790 Use of hydro-monobenzoporphyrins to mediate the destruction of unwanted cells or tissues by irradiation
11/23/1989EP0342665A2 Physiologically active substance tan-931, its derivatives, their production and use
11/23/1989EP0342427A2 Strobilurinderivatives, their preparation and use
11/23/1989EP0342341A2 Process for producing antitumor antibiotic LL-E33288Gamma2
11/23/1989DE3915317A1 Verwendung von gonadoliberinderivaten Use of gonadoliberinderivaten
11/21/1989US4882452 Crystallization, antitumor
11/21/1989US4882435 Pharmaceutical preparations
11/21/1989US4882421 Pharmaceutical for treating tumors and method for making it
11/21/1989US4882319 Phosphonic acid substituted aromatic steroids as inhibitors of steroid 5-α-reductase
11/21/1989US4882318 Administering heparin or suitable derivative
11/21/1989US4882147 Substituted with mercapto groups and fluorine at 5 position of cytosine and uracil bases
11/21/1989CA1263120A1 Process for the preparation of n-sulfamyl-3-(2- guanidino-thiazol-4-yl-methylthio)-propionamidine
11/16/1989WO1989010961A1 Peptide analogs and their use as haptens to elicit catalytic antibodies
11/16/1989WO1989010929A2 New l-fucose analogs, method of preparation, application of such analogs to the preparation of new glycals, anthracyclines obtained with said glycals and utilization of said anthracyclines as drugs
11/16/1989WO1989010928A1 Platinum-polymer complexes and their use as antitumor agents
11/16/1989WO1989010758A1 Compounds, compositions and method for binding bio-affecting substances to surface membranes of bio-particles
11/16/1989WO1989010754A1 Therapeutic methods using catalytic antibodies
11/16/1989WO1989010735A1 Probursin
11/15/1989EP0342015A2 Peptides, their use and pharmaceutical compositions containing them
11/15/1989EP0341837A2 Glutamic acid derivatives
11/15/1989EP0341734A2 Proteins having anti-tumor activity
11/15/1989EP0341649A1 Antibiotic aranorosin, microbiological process for its preparation and its use as a medicament
11/15/1989EP0341558A2 Use and agent for diminishing the secondary effects of TNF
11/15/1989EP0341409A1 Platinum (II) complexes, their preparation and use as antitumour agents
11/15/1989EP0341304A1 Improved ricin molecules and ricin toxin conjugates
11/15/1989EP0341303A1 Monoclonal antibody against the rgd-directed adhesion receptor of endothelial cells
11/15/1989EP0341252A1 Human polymorphic epithelial mucin polypeptides for use in therapy and diagnosis
11/15/1989CN1037174A Novel revombinant and chimeric antibodies directed against human adenocarcinoma
11/14/1989US4880918 Arrest and killing of tumor cells by adenosine 5-diphosphate and adenosine-5-triphosphate
11/14/1989US4880839 Acyanilide derivatives
11/14/1989US4880812 Antitumor agents
11/14/1989US4880803 Method of inducing immunostimulating activity
11/14/1989US4880791 Blood disorders
11/14/1989US4880790 Anticancer, antitumor agents
11/14/1989US4880637 Compositions of catecholic butanes with zinc
11/14/1989US4880635 Dehydrated liposomes
11/14/1989US4880626 Immunology, vaccines
11/14/1989CA1262862A1 Tetrapyrrole therapeutic agents
11/08/1989EP0341213A2 5-Aryl-substituted-2,3-dihydro-imidazo [1,2-a]furo[3,2-c]- or thieno[2,3-c]pyridines
11/08/1989EP0341154A2 Analogues of L-fucose, process for their preparation, their application for the preparation of glycals, anthracycline derivatives of the glycals and the use of the anthracyclines as medicaments
11/08/1989EP0341104A2 Substituted flavonoid compounds, their salts, their manufacture and medicines containing these materials
11/08/1989EP0341100A2 DNA coding for thymosin and TNF
11/08/1989EP0340905A1 Fused pyrimidines, their production and use
11/08/1989EP0340333A2 Novel physiologically active polypeptide and pharmaceutical composition
11/08/1989EP0340243A1 Cc-1065 analogs.
11/08/1989CN1036988A Antibody heteroconjugates for use in regulation lymphocyte activity
11/07/1989US4879379 Novel platinum-steroid complexes
11/07/1989US4879278 Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 15
11/07/1989US4879226 Novel human physiologically active polypeptide
11/02/1989WO1989010412A1 Detection of neu gene expression and products
11/02/1989WO1989010403A1 Human gm-csf variants
11/02/1989WO1989010355A1 Derivatives of tryptophan as cck antagonists
11/02/1989WO1989010353A1 Compounds effective in inducing cell differentiation
11/02/1989WO1989010352A1 SIDE CHAIN UNSATURATED 1alpha-HYDROXYVITAMIN D HOMOLOGS
11/02/1989WO1989010351A1 Novel vitamin d analogues
11/02/1989WO1989010140A1 Further improvements relating to drug delivery systems
11/02/1989WO1989010133A1 Stem cell inhibitors
11/02/1989EP0340153A1 N-substituted imidazoles, process for their preparation and their use in medicaments
11/02/1989EP0339976A1 Anti-tumour agents
11/02/1989EP0339772A1 Platinum chemotherapeutic product
11/02/1989EP0339681A2 Antitumor antibiotic substance